PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcmudisBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Musculoskeletal Disorders
 
BMC Musculoskelet Disord. 2012; 13: 158.
Published online Aug 27, 2012. doi:  10.1186/1471-2474-13-158
PMCID: PMC3495205
Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study
William A Blumentals,1 Anna Arreglado,1 Pavel Napalkov,2 and Stephen Tooveycorresponding author3,4
1Hoffmann-La Roche, Inc, Nutley, NJ, USA
2Genentech, Inc, South San Francisco, CA, USA
3Royal Free and University College Medical School, London, UK
4Burggartenstrasse 32, 4103, Bottmingen, Switzerland
corresponding authorCorresponding author.
William A Blumentals: william.blumentals/at/roche.com; Anna Arreglado: anna.arreglado/at/roche.com; Pavel Napalkov: napalkov.pavel/at/gene.com; Stephen Toovey: malaria/at/sunrise.ch
Received November 15, 2011; Accepted August 9, 2012.
Abstract
Background
Patients with rheumatoid arthritis (RA) are known to be at increased risk of infection, particularly if they are taking drugs with immunomodulatory effects. There is a need for more information on the risk of influenza in patients with RA.
Methods
A retrospective cohort study was carried out using data gathered from a large US commercial health insurance database (Thomson Reuters Medstat MarketScan) from 1 January 2000 to 31 December 2007. Patients were ≥18 years of age, with at least two RA claims diagnoses. The database was scanned for incidence of seasonal influenza and its complications on or up to 30 days after an influenza diagnosis in RA patients and matched controls. Other factors accounted for included medical conditions, use of disease-modifying anti-rheumatic drugs (DMARDs), use of biological agents, influenza vaccination and high- or low-dose corticosteroids. Incidence rate ratios (IRRs) were calculated for influenza and its complications in patients with RA.
Results
46,030 patients with RA and a matching number of controls had a median age of 57 years. The incidence of influenza was higher in RA patients than in controls (409.33 vs 306.12 cases per 100,000 patient-years), and there was a 2.75-fold increase in incidence of complications in RA. Presence or absence of DMARDs or biologics had no significant effect. The adjusted IRR of influenza was statistically significant in patients aged 60–69 years, and especially among men. A significantly increased rate of influenza complications was observed in women and in both genders combined (but not in men only) when all age groups were combined. In general, the risk of influenza complications was similar in RA patients not receiving DMARDs or biologics to that in all RA patients. Pneumonia rates were significantly higher in women with RA. Rates of stroke/myocardial infarction (MI) were higher in men, although statistical significance was borderline.
Conclusions
RA is associated with increased incidence of seasonal influenza and its complications. Gender- and age-specific subgroup data indicate that women generally have a greater rate of complications than men, but that men primarily have an increased rate of stroke and MI complications. Concomitant DMARD or biological use appears not to significantly affect the rate of influenza or its complications.
Articles from BMC Musculoskeletal Disorders are provided here courtesy of
BioMed Central